Cancer is a multifactorial disease that affects millions of individuals worldwide and has a profound impact on public health. The heterogeneity of solid ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Blood centres cannot make cell therapies more accessible on their own. For decades they have partnered with hospitals to ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

Microbial neutralization must constantly achieve a six-log reduction threshold of Geobacillus stearothermophilus and comply ...

Bryan Johnson, who’s spending hundreds of millions of dollars on treatments designed to extend his life, is many things to many people: a daring pioneer and a reckless fool; a selfless crusader and an ...

Sangamo (SGMO) stock faces challenges as Pfizer terminates partnership for hemophilia A gene therapy, impacting share price ...

Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.